Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Ericsson

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2001
Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the worldJ A Adachi, Z D Jiang, J J Mathewson, et al.
JAMA|January 18, 1980
Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth)H L DuPont, P Sullivan, D G Evans, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trialH L DuPont, Z D Jiang, C D Ericsson, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2001
Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the worldJ A Adachi, Z D Jiang, J J Mathewson, et al.
JAMA|January 18, 1980
Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth)H L DuPont, P Sullivan, D G Evans, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trialH L DuPont, Z D Jiang, C D Ericsson, et al.
Pageof 11